Quarterly report pursuant to Section 13 or 15(d)

STOCK WARRANTS

v3.20.1
STOCK WARRANTS
3 Months Ended
Mar. 31, 2020
Stock Warrants Abstract  
STOCK WARRANTS

NOTE 9 – STOCK WARRANTS

 

The following table summarizes information with respect to outstanding warrants to purchase common stock of the Company at March 31, 2020:

 

Exercise

 

 

Number

 

 

Expiration

Price

 

 

Outstanding

 

 

Date

$

0.57

 

 

 

2,500

 

 

 

November 2020

$

0.57

 

 

 

2,344,198

 

 

 

November 2024

$

0.57

 

 

 

2,341,026

 

 

 

February 2025

$

35.00

 

 

 

490,571

 

 

 

December 2023

$

630.00

 

 

 

5,441

 

 

 

   October 2021

$

687.50

 

 

 

474

 

 

 

   October 2021

 

 

 

 

 

5,184,210

 

 

 

 

 

During the quarter ended March 31, 2020, 2.3 million warrants from the November 2019 financing, with an exercise price of $0.57, were exercised for proceeds of approximately $1.3 million.

 

During the quarter ended March 31, 2020, 10.8 million warrants from the February 7th financing, with an exercise price of $0.57, were exercised for proceeds of approximately $6.2 million.

 

During the quarter ended March 31, 2019, 2,000 warrants with an exercise price of $35.00 were exercised for proceeds of approximately $70,000.

 

During the quarter ended March 31, 2019, 24 warrants with an exercise price of $25,000 expired.